Outcomes with DA-EPOCH-R in the Treatment of Aggressive B Cell Lymphoma

被引:0
|
作者
Boddy, Craig [1 ,2 ]
Galvez, Carlos [2 ]
Pro, Barbara [1 ,2 ]
Fought, Angela [2 ]
Gordon, Leo [1 ,2 ]
Winter, Jane [1 ,2 ]
Ma, Shuo [1 ,2 ]
Karmali, Reem [1 ,2 ]
Kaplan, Jason [1 ,2 ]
机构
[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Med, Chicago, IL 60611 USA
来源
关键词
D O I
10.1016/j.clml.2017.07.199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
NHL-046
引用
收藏
页码:S364 / S365
页数:2
相关论文
共 50 条
  • [1] THE TREATMENT OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE ERA OF DA-EPOCH-R
    Lancia, F.
    Rigacci, L.
    Kovalchuk, S.
    Fabbri, E.
    Puccini, B.
    Mannelli, L.
    Benelli, G.
    Bosi, A.
    HAEMATOLOGICA, 2015, 100 : 147 - 147
  • [2] DA-EPOCH-R Has Comparable Outcomes in De Novo and Transformed Diffuse Large B Cell Lymphoma
    Desai, Sanjal H.
    Chaturvedi, Mansi
    Hameed, Rumaisa
    Sosa, Valentina Baez
    Shenoy, Aarthi
    BLOOD, 2020, 136
  • [3] DA-EPOCH-R Has Comparable Outcomes in De Novo and Transformed Diffuse Large B Cell Lymphoma
    Desai, Sanjal H.
    Chaturvedi, Mansi
    Hameed, Rumaisa
    Sosa, Valentina Baez
    Shenoy, Aarthi
    BLOOD, 2020, 136
  • [4] Efficacy and Feasibility of DA-EPOCH-R in Aggressive B-Cell Lymphoma: A Real Life Single-Center Analysis
    Marino, Fabrizio
    Balzarotti, Monica
    Ricci, Francesca
    Mazza, Rita
    Santoro, Armando
    Carlo-Stella, Carmelo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S250 - S250
  • [5] PRIMARY MEDIASTINAL LYMPHOMA IN THE DA-EPOCH-R ERA
    Garcia, Bacelar Ana
    Gomez, Garcia Lara Maria
    De La Fuente, Graciani Ignacio
    Bourgeois, Garcia Monique
    Garcia, de Coca Alfonso
    Cuello, Garcia Rebeca
    Bombin, Canal Carolina
    Cebeira, Moro Maria Jose
    Golvano, Guerrero Eva Maria
    Caballero, Berrocal Juan Carlos
    Perez, Gonzalez Sonia
    Perez, Martinez Carmen
    Acevedo, Garcia Rosa
    Tamayo, Velasco Alvaro
    Penarrubia, Ponce Maria Jesus
    HAEMATOLOGICA, 2020, 105 : 307 - 308
  • [6] Impact of Interim FDG-PET (iPET) in the Outcomes of Patients with Aggressive B-Cell Lymphomas Receiving DA-EPOCH-R
    Phuoc, Vania
    Isenalumhe, Leidy
    Saeed, Hayder
    Bello, Celeste
    Shah, Bijal
    Sokol, Lubomir
    Chavez, Julio
    BLOOD, 2019, 134
  • [7] Da-Epoch-R and Epoch-R in treatment of adolescent patients with DLBCL
    Kirov, I.
    Neudorf, S.
    Sender, L.
    Messina, J.
    English, M.
    Crook, N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 64 - 65
  • [8] DA-EPOCH-R in Aggressive CD 20 Positive B Cell Lymphomas: Real-World Experience
    Prasanth Ganesan
    Trivadi S. Ganesan
    Harshvardhan Atreya
    Krishnarathinam Kannan
    Venkatraman Radhakrishnan
    Manikandan Dhanushkodi
    Thanda Lucy Ann Joshua
    Shirley Sundersingh
    Tenali Gnana Sagar
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 454 - 459
  • [9] DA-EPOCH-R in Aggressive CD 20 Positive B Cell Lymphomas: Real-World Experience
    Ganesan, Prasanth
    Ganesan, Trivadi S.
    Atreya, Harshvardhan
    Kannan, Krishnarathinam
    Radhakrishnan, Venkatraman
    Dhanushkodi, Manikandan
    Joshua, Thanda Lucy Ann
    Sundersingh, Shirley
    Sagar, Tenali Gnana
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (03) : 454 - 459
  • [10] Preliminary Report of a Multicenter Prospective Phase II Study of DA-EPOCH-R in MYC-Rearranged Aggressive B-Cell Lymphoma
    Dunleavy, Kieron
    Fanale, Michelle
    LaCasce, Ann
    Noy, Ariela
    Caimi, Paolo
    Parekh, Samir
    Hayslip, John W.
    Jagadeesh, Deepa
    Lord, Raymond S.
    Lechowicz, Mary J.
    Gaur, Rakesh
    Lucas, Andrea
    Staudt, Louis M.
    Steinberg, Seth M.
    Kahl, Brad
    Friedberg, Jonathan W.
    Little, Richard F.
    Bartlett, Nancy L.
    Wilson, Wyndham H.
    BLOOD, 2014, 124 (21)